Jane Street’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
Other funds holding NPCE
Jane Street's NPCE Position: Q3 2026 in Review
Jane Street reduced its Neuropace (NPCE) stake by 59% in Q3 2026, selling an estimated $299K and leaving 14,271 shares worth $196K. The position accounts for ﹤0.01% of the portfolio, ranked #10107.
Jane Street first reported a position in NPCE in Q2 2021 and has held it in 8 quarters since. The position peaked at $1.82M in Q4 2025. 105 funds tracked by Wall St. Rank hold NPCE as of Q3 2026.
- Jane Street held 14,271 shares of Neuropace worth $196K as of Q3 2026.
- Jane Street sold 20,167 Neuropace shares in Q3 2026, an estimated $299K.
- Neuropace made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #10107 holding.
- Jane Street first reported a position in Neuropace in Q2 2021 and has held it in 8 quarters since.
- Jane Street's Neuropace position peaked at $1.82M in Q4 2025.
- 105 funds tracked by Wall St. Rank held Neuropace as of Q3 2026.
Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.